Kindred Biosciences (KIN) Tops Q4 EPS by 12c

Kindred Biosciences (NASDAQ: KIN) reported Q4 EPS of ($0.32), $0.12 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c